Business Services Industry

GlaxoSmithKline is caught in Seroxat crossfire.

Knight Ridder/Tribune Business News, September, 2004

By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business News

Sep. 30--GlaxoSmithKline is facing more flak over its controversial antidepressant Seroxat.

The company is getting it in the neck over a leaked memo urging sales staff to withhold sensitive information on the drug from doctors in the US.

And a Panorama investigation for the BBC will reveal that regulators have known for 13 years of the treat-ment's link with suicide.

To add to its woes, filmmaker Michael Moore has his lens trained on the pharmaceuticals giant for a documentary on corporate America. "Fahrenheit 9/11," his epic on George Bush and the Iraq war, caused uproar when it was screened in the US.

Glaxo shares fell 18p to UKpound 11.91. It was...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here